Search - tctmd.com

Displaying 1 - 20 of 2449

Sort: Relevancy | Date

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

March 25, 2026

Two Conduction-System Pacing RCTs Give Conflicting Results

News Daily News

Two Conduction-System Pacing RCTs Give Conflicting Results

March 20, 2026

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

News Daily News

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

Yael L. Maxwell

March 12, 2026

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

News Daily News

Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI

March 10, 2026

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

News Daily News

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

March 06, 2026

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

News Daily News

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

February 19, 2026

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

Side Effects of Statins Might Be Overstated: CTT Collaboration

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

Meta-analysis Teases Out What Drives Success in M-TEER

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

February 10, 2026

Q&A Lior Jankelson on AI Tools for Suspected ACS and More

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

February 10, 2026

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

February 04, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

January 29, 2026

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

News Daily News

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

January 23, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.